Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Lancet (London, England)
|
October 14, 1989
Postoperative pyrexia, atropine, and malaria
R Bohmer
Journal of Vascular Surgery
|
August 27, 1998
Critical pathways at Massachusetts General Hospital
R Bohmer
Lancet (London, England)
|
October 29, 1988
Non-availability of ether
R Bohmer, R M Grounds
Harvard Business Review
|
January 6, 2001
Will disruptive innovations cure health care?
C M Christensen, R Bohmer, J Kenagy
The Australian and New Zealand Journal of Surgery
|
January 9, 2001
Parathyroid adenoma localization with 99mTc-MDP bone scintigraphy
D R Bohmer, M P Mercer, G J Turner
Chest
|
August 1, 1987
Cholesterol in pleural effusions. A diagnostic aid
H Hamm, U Brohan, R Bohmer, et al.
BMC Cancer
|
March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
R Mercieca-Bebber, E H Barnes, K Wilson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Lancet (London, England)
|
October 14, 1989
Postoperative pyrexia, atropine, and malaria
R Bohmer
Journal of Vascular Surgery
|
August 27, 1998
Critical pathways at Massachusetts General Hospital
R Bohmer
Lancet (London, England)
|
October 29, 1988
Non-availability of ether
R Bohmer, R M Grounds
Harvard Business Review
|
January 6, 2001
Will disruptive innovations cure health care?
C M Christensen, R Bohmer, J Kenagy
The Australian and New Zealand Journal of Surgery
|
January 9, 2001
Parathyroid adenoma localization with 99mTc-MDP bone scintigraphy
D R Bohmer, M P Mercer, G J Turner
Chest
|
August 1, 1987
Cholesterol in pleural effusions. A diagnostic aid
H Hamm, U Brohan, R Bohmer, et al.
BMC Cancer
|
March 16, 2022
Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
R Mercieca-Bebber, E H Barnes, K Wilson, et al.
Page
of 1